Short Interest in Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) Drops By 50.0%

Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) was the recipient of a significant decrease in short interest in June. As of June 30th, there was short interest totalling 200 shares, a decrease of 50.0% from the June 15th total of 400 shares. Based on an average trading volume of 2,300 shares, the days-to-cover ratio is presently 0.1 days.

Clinuvel Pharmaceuticals Stock Performance

Shares of CLVLY traded up $0.05 during trading hours on Friday, reaching $10.35. The company had a trading volume of 254 shares, compared to its average volume of 3,218. Clinuvel Pharmaceuticals has a 12-month low of $8.54 and a 12-month high of $13.55. The firm has a 50 day simple moving average of $10.05 and a 200-day simple moving average of $9.96.

Clinuvel Pharmaceuticals Company Profile

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).